Fibrocaps: Phase II data

The single-blind, U.S. Phase II FC-002 US trial in 70 patients undergoing spinal, peripheral vascular or general surgery showed that topical Fibrocaps followed

Read the full 230 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE